Abbvie Inc (NYSE: ABBV) is -1.21% lower on its value in year-to-date trading and has touched a low of $153.58 and a high of $207.32 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ABBV stock was last observed hovering at around $176.74 in the last trading session, with the day’s loss setting it -1.19%.
Currently trading at $175.55, the stock is -0.71% and -2.07% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.76 million and changing -0.67% at the moment leaves the stock -1.81% off its SMA200. ABBV registered 7.19% gain for a year compared to 6-month gain of 4.48%. The firm has a 50-day simple moving average (SMA 50) of $179.7772 and a 200-day simple moving average (SMA200) of $178.8016.
The stock witnessed a 0.68% loss in the last 1 month and extending the period to 3 months gives it a -9.60%, and is -2.53% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.98% over the week and 1.86% over the month.
Abbvie Inc (ABBV) has around 50000 employees, a market worth around $310.22B and $55.53B in sales. Current P/E ratio is 61.22 and Fwd P/E is 14.39. Profit margin for the company is 9.15%. Distance from 52-week low is 14.31% and -15.32% from its 52-week high. The company has generated returns on investments over the last 12 months (7.87%).
with sales reaching $14.8B over the same period.The EPS is expected to shrink by -1.53% this year, but quarterly earnings will post 3.15% year-over-year. Quarterly sales are estimated to grow 3.52% in year-over-year returns.
Abbvie Inc (ABBV) Top Institutional Holders
4294.0 institutions hold shares in Abbvie Inc (ABBV), with institutional investors hold 73.55% of the company’s shares. The shares outstanding are 1.77B, and float is at 1.77B with Short Float at 0.96%. Institutions hold 73.48% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 170.66 million shares valued at $29.27 billion. The investor’s holdings represent 9.6472% of the ABBV Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 136.43 million shares valued at $23.4 billion to account for 7.7124 of the shares outstanding. The other top investors are STATE STREET CORP which holds 77.8 million shares representing 4.398% and valued at over $13.34 billion, while JPMORGAN CHASE & CO holds 3.0276 of the shares totaling 53.56 million with a market value of $9.19 billion.
Abbvie Inc (ABBV) Insider Activity
The most recent transaction is an insider sale by Buckbee Kevin K, the company’s SVP, CONTROLLER. SEC filings show that Buckbee Kevin K sold 1,800 shares of the company’s common stock on Dec 16 ’24 at a price of $172.24 per share for a total of $0.31 million. Following the sale, the insider now owns 6983.0 shares.
Still, SEC filings show that on Aug 08 ’24, Hudson Thomas J (Officer) Proposed Sale 49,170 shares at an average price of $189.08 for $9.3 million. The insider now directly holds shares of Abbvie Inc (ABBV).
